Analystreport

Correvio Pharma Corp (NASDAQ: CORV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.50 price target on the stock.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report